At ASH 2025, sonrotoclax demonstrated encouraging response rates and a favorable safety profile as a single-agent BCL2 ...
A pharmacist-led clinic achieved a 94.3% success rate in venetoclax ramp-up for patients with CLL, minimizing serious TLS incidents. Pharmacists independently managed TLS prophylaxis and drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback